Most cited papers from Utah Cancer Specialists

Utah Cancer Specialists

What are the most cited papers from Utah Cancer Specialists?

The most cited paper from Utah Cancer Specialists is "Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study" (Ghassan K. Abou‐Alfa et al., 2020), with 1,117 citations. Next come "Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial" (569) and "Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation" (503).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 13 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study Ghassan K. Abou‐Alfa et al. · The Lancet Oncology Open access	13 May 2020	1,117
2	Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan et al. · The Lancet Oncology	12 Feb 2016	569
3	Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation Andrew Xiuxuan Zhu et al. · JAMA Oncology Open access	23 Sep 2021	503
4	Zoledronic Acid Inhibits Adjuvant Letrozole–Induced Bone Loss in Postmenopausal Women With Early Breast Cancer Adam Brufsky, W. Graydon Harker, Joseph Thaddeus Beck et al. · Journal of Clinical Oncology Open access	12 Dec 2006	321
5	Impact of Time-of-Flight on PET Tumor Detection D.J. Kadrmas, Michael Casey, Maurizio Conti et al. · Journal of Nuclear Medicine Open access	17 Jul 2009	282
6	Randomized Phase III Study of Exatecan and Gemcitabine Compared With Gemcitabine Alone in Untreated Advanced Pancreatic Cancer Ghassan K. Abou‐Alfa, Richard Létourneau, Graydon Harker et al. · Journal of Clinical Oncology Open access	18 Sep 2006	281
7	A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not? Michael E. Carney, Johnathan M. Lancaster, Clyde D. Ford et al. · Gynecologic Oncology	2002	209
8	Final 5‐year results of Z‐FAST trial Adam Brufsky, W. Graydon Harker, Joseph Thaddeus Beck et al. · Cancer	10 Oct 2011	192
9	Dietary Beta Carotene and Lung Cancer Risk in U.S. Nonsmokers S. T. Mayne, Dwight T. Janerich, Peter Wagoner Greenwald et al. · JNCI Journal of the National Cancer Institute	5 Jan 1994	189
10	Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone Gabriel N. Hortobágyi, Catherine H. Van Poznak, W. Graydon Harker et al. · JAMA Oncology Open access	26 Jan 2017	164
11	Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers. Chang‐Yeol Yim, Neil R. Bastian, Jeffrey C. Smith et al. · PubMed	15 Nov 1993	109
12	Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies Andres Forero‐Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub et al. · Blood Open access	26 Feb 2019	100
13	The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence--Data from the Utah Cancer Registry Robert A. Stephenson, Charles R. Smart, Geraldine P. Mineau et al. · Cancer	Apr 1996	99
14	Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients Meredith S. Shiels, Glenn E. Copeland, Marc T. Goodman et al. · Cancer Open access	4 Mar 2015	94
15	ClarIDHy: A global, phase III, randomized, double-blind study of ivosidenib (IVO) vs placebo in patients with advanced cholangiocarcinoma (CC) with an isocitrate dehydrogenase 1 (IDH1) mutation Ghassan K. Abou‐Alfa, Teresa Macarulla Mercade, Milind M. Javle et al. · Annals of Oncology Open access	Oct 2019	88
16	Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma Justin Z. Wang et al. · Nature Medicine Open access120 authors	21 Aug 2024	79
17	Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah Mia Hashibe, Anne C. Kirchhoff, Deanna Kepka et al. · Cancer Medicine Open access	13 Mar 2018	75
18	Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer Leonard B. Saltz, Suprith Badarinath, Shaker R. Dakhil et al. · Clinical Colorectal Cancer	5 Nov 2011	68
19	A Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel With or Without Trastuzumab in Metastatic Breast Cancer Barry C. Mirtsching, Thomas M. Cosgriff, Graydon Harker et al. · Clinical Breast Cancer	Apr 2011	67
20	Arrhythmia insensitive rapid cardiac T1 mapping pulse sequence Michelle Susannah Fitts, Élodie Breton, Eugene G. Kholmovski et al. · Magnetic Resonance in Medicine Open access	27 Dec 2012	66
21	Update on pediatric cancer predisposition syndromes Joshua David Schiffman, James I. Geller, Erin Mundt et al. · Pediatric Blood & Cancer	26 Apr 2013	65
22	Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score Kimberly A. Herget, Darshan P. Patel, Heidi A. Hanson et al. · Cancer Medicine Open access	2 Dec 2015	62
23	ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study Melissa Johnson, Arkadiusz Z. Dudek, Ammar Sukari et al. · Clinical Cancer Research Open access	18 Mar 2022	59
24	Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study Sean Patrick Soisson, Patricia A. Ganz, David K. Gaffney et al. · Gynecologic Oncology Open access	27 Dec 2017	59
25	Phase I Trial of Targeted EGFR or ALK Therapy with Ipilimumab in Metastatic NSCLC with Long-Term Follow-Up Anna Weinberg Chalmers, Shiven B. Patel, Kenneth M. Boucher et al. · Targeted Oncology	25 Jul 2019	52
26	Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage? Robert C. Leonard, Joyce O’Shaughnessy, Svetislava J. Vukelja et al. · Annals of Oncology Open access	Sep 2006	52
27	Stress Fracture of the Fifth Metatarsal After Evans' Calcaneal Osteotomy: A Report of Two Cases James S. Davitt, James M. Morgan · Foot & Ankle International	Oct 1998	52
28	EWS/FLI utilizes NKX2-2 to repress mesenchymal features of Ewing sarcoma John Fadul, Russell N. Bell, Laura M. Hoffman et al. · Genes & Cancer Open access	17 Apr 2015	48
29	Aging-Related Disease Risks among Young Thyroid Cancer Survivors Brenna E. Blackburn, Patricia A. Ganz, Kerry G. Rowe et al. · Cancer Epidemiology Biomarkers & Prevention Open access	22 Nov 2017	46
30	Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study Sean Patrick Soisson, Patricia A. Ganz, David K. Gaffney et al. · JNCI Journal of the National Cancer Institute Open access	20 Mar 2018	43
31	Model‐based reconstruction of undersampled diffusion tensor k‐space data Christopher L. Welsh, Edward DiBella, Ganesh Adluru et al. · Magnetic Resonance in Medicine Open access	28 Sep 2012	43
32	A Burnout Reduction and Wellness Strategy: Personal Financial Health for the Medical Trainee and Early Career Radiation Oncologist Trevor Joseph Royce, Kathleen Davenport, James M. Dahle · Practical Radiation Oncology Open access	7 Mar 2019	40
33	Risk of valvular heart disease associated with use of fenfluramine Paul Nathan Hopkins, Gerald I Polukoff · BMC Cardiovascular Disorders Open access	11 Jun 2003	38
34	Rural–urban disparities in colorectal cancer survival and risk among men in Utah: a statewide population-based study Charles R. Rogers, Brenna E. Blackburn, Matthew Huntington et al. · Cancer Causes & Control Open access	30 Jan 2020	37
35	Three‐dimensional late gadolinium enhancement imaging of the left atrium with a hybrid radial acquisition and compressed sensing Ganesh Adluru, Liyong Chen, Seong‐Eun Kim et al. · Journal of Magnetic Resonance Imaging Open access	3 Oct 2011	35
36	The fetal antigen hypothesis for breast cancer, revisited Dwight T. Janerich · Medical Hypotheses	Aug 1994	34
37	An 11‐channel radio frequency phased array coil for magnetic resonance guided high‐intensity focused ultrasound of the breast Emilee Minalga, Allison Payne, Robb Merrill et al. · Magnetic Resonance in Medicine Open access	16 Mar 2012	32
38	Dietary relationships with early onset (under age 45) breast cancer in a case-control study in the United States: influence of chemotherapy treatment Nancy A. Potischman, Christine A. Swanson, Ralph J. Coates et al. · Cancer Causes & Control	Sep 1997	32
39	Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards Melissa S. Dillmon, Erin B. Kennedy, Mary K. Anderson et al. · Journal of Clinical Oncology	9 Dec 2019	31
40	Wideband arrhythmia‐Insensitive‐rapid (AIR) pulse sequence for cardiac T1 mapping without image artifacts induced by an implantable‐cardioverter‐defibrillator Kyungpyo Hong, Eun‐Kee Jeong, T. Scott Wall et al. · Magnetic Resonance in Medicine Open access	14 May 2015	31
41	Relative RF coil performance in carotid imaging J. Rock Hadley, John A. Roberts, K. Craig Goodrich et al. · Magnetic Resonance Imaging	Jun 2005	31
42	Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database Philip J. Lupo, Heather E. Danysh, Sharon E. Plon et al. · Cancer Medicine Open access	23 Mar 2015	30
43	PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial Stephen Chia et al. · Breast Cancer Research Open access	11 Mar 2019	28
44	Real‐Time MRI‐Guided Cardiac Cryo‐Ablation: A Feasibility Study Eugene G. Kholmovski, Nicolas Coulombe, Joshua Silvernagel et al. · Journal of Cardiovascular Electrophysiology Open access	9 Feb 2016	26
45	Red Blood Cell Enzymopathies Xylina T. Gregg, Josef T. Prchal · Elsevier eBooks Book chapter	8 Sep 2017	25
46	Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design Rupesh R Kotecha et al. · Neuro-Oncology ReviewOpen access	10 Jan 2025	24
47	A phase II study of bevacizumab and erlotinib as initial treatment for metastatic non-squamous, non-small cell lung cancer with serum proteomic evaluation Wallace Akerley, Kenneth M. Boucher, N. Rich et al. · Lung Cancer	25 Dec 2012	24
48	Discrepancies between tumor genomic profiling and germline genetic testing Kristen Pauley, Cathryn Koptiuch, Samantha E. Greenberg et al. · ESMO Open Open access	30 Jun 2022	22
49	Linkage between Utah All Payers Claims Database and Central Cancer Registry Jennifer Hornung Garvin, Kimberly A. Herget, Mia Hashibe et al. · Health Services Research Open access	24 Jan 2019	22
50	Accuracy and reliability of stitched cone-beam computed tomography images Nicholas Egbert, David Richard Cagna, Swati A. Ahuja et al. · Imaging Science in Dentistry Open access	2015	21

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.